Cardiovascular Benefits of Empagliflozin Are Associated With Gut Microbiota and Plasma Metabolites in Type 2 Diabetes
恩格列净的心血管益处与 2 型糖尿病患者的肠道菌群和血浆代谢物有关
期刊:Journal of Clinical Endocrinology & Metabolism
影响因子:5
doi:10.1210/clinem/dgac210
Xinru Deng, Chenhong Zhang, Pengxu Wang, Wei Wei, Xiaoyang Shi, Pingping Wang, Junpeng Yang, Limin Wang, Shasha Tang, Yuanyuan Fang, Yalei Liu, Yiqi Chen, Yun Zhang, Qian Yuan, Jing Shang, Quane Kan, Huihui Yang, Hua Man, Danyu Wang, Huijuan Yuan